Acadia Healthcare (NASDAQ:ACHC) Upgraded at KeyCorp

KeyCorp upgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a sector weight rating to an overweight rating in a research report report published on Tuesday morning, MarketBeat Ratings reports. They currently have $70.00 target price on the stock. KeyCorp also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.73 EPS, FY2024 earnings at $3.39 EPS, Q1 2025 earnings at $0.66 EPS, Q2 2025 earnings at $0.85 EPS, Q3 2025 earnings at $0.92 EPS, Q4 2025 earnings at $0.77 EPS, FY2025 earnings at $3.20 EPS and FY2026 earnings at $3.98 EPS.

Other analysts also recently issued reports about the stock. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their target price for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Royal Bank of Canada cut their price target on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday, November 18th. Barclays decreased their price objective on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a report on Friday, November 22nd. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, December 10th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, Acadia Healthcare currently has an average rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Trading Down 0.0 %

Acadia Healthcare stock opened at $45.12 on Tuesday. The business’s 50-day simple moving average is $40.48 and its 200-day simple moving average is $58.19. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77. The firm has a market capitalization of $4.19 billion, a PE ratio of 14.79, a PEG ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. During the same period in the previous year, the business posted $0.91 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities research analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Trading of Acadia Healthcare

Several institutional investors have recently bought and sold shares of the stock. GAMMA Investing LLC grew its position in Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after acquiring an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Acadia Healthcare during the second quarter worth $59,000. Covestor Ltd increased its stake in shares of Acadia Healthcare by 834.4% in the third quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after buying an additional 1,018 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new position in shares of Acadia Healthcare in the third quarter valued at about $86,000. Finally, Assetmark Inc. lifted its position in Acadia Healthcare by 66.1% during the 3rd quarter. Assetmark Inc. now owns 1,485 shares of the company’s stock worth $94,000 after buying an additional 591 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.